Five years of newborn screening for Pompe, Mucopolysaccharidosis type I, Gaucher, and Fabry diseases in Oregon
In October 2018, the Oregon newborn screening program began screening for four lysosomal storage disorders (LSDs) Pompe, Mucopolysaccharidosis Type I (MPSI), Gaucher, and Fabry. The laboratory used two different methodologies, digital microfluidics and tandem mass spectrometry, to measure the four L...
Saved in:
| Main Authors: | Sarah Viall, Patrice Held |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | Molecular Genetics and Metabolism Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2214426925000369 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Newborn Screening for Gaucher Disease: The New Jersey Experience
by: Caitlin Menello, et al.
Published: (2025-05-01) -
Effect of newborn genomic screening for lysosomal storage disorders: a cohort study in China
by: Xin Wang, et al.
Published: (2025-05-01) -
Newborn Screening for Gaucher Disease: Parental Stress and Psychological Burden
by: Chiara Cazzorla, et al.
Published: (2025-02-01) -
Japanese experience of newborn screening for lysosomal storage diseases and adrenoleukodystrophy
by: Takanori Onuki, et al.
Published: (2025-07-01) -
Exploratory Study on the Challenges of Newborn Screening for Lysosomal Storage Disorders Emphasizes the Need for Multitier Testing and Collaborative Approaches to Management
by: A. Terrell, et al.
Published: (2025-07-01)